- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04940598
High Intensity Interval Exercise SCI
July 2, 2024 updated by: Gordon Fisher, University of Alabama at Birmingham
Telehealth High Intensity Interval Exercise and Cardiometabolic Health in Spinal Cord Injury
This study will determine if the implementation of a home-based telehealth high intensity interval exercise-training (HIIT)program can significantly improve cardiometabolic health and physical function in a cohort of individuals with longstanding spinal cord injury (SCI).
Results from this study will determine feasibility, overall enjoyment, and health impact of implementing a home-based telehealth HIIT program in individuals with SCI.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
For individuals with spinal cord injury (SCI), exercise participation reduces the risk of developing chronic cardiometabolic diseases, which are leading causes of rehospitalization and death within this population.
Accordingly, recent SCI exercise guidelines have highlighted a need for exercise trials that can improve cardiometabolic factors such as glucose tolerance, blood lipids, blood pressure, and body composition.
However, to date, the number of exercise trials examining these cardiometabolic outcomes in SCI is low, and these exercise regimens are often inconvenient for individuals with SCI to perform within their community.
In addition to the functional impairment associated with the disability, individuals with SCI experience a number of barriers to exercise participation, such as lack of time (e.g.
conflict with work schedule), accessible or usable equipment and facilities, and transportation.
Thus, it is important to identify effective modes of exercise that can improve overall health but do not require a significant overall weekly time commitment.
Investigators recently demonstrated that individuals with SCI could safely perform high intensity interval training (HIIT) using arm crank cycling and that as few as two days per week of HIIT could improve cardiometabolic health.
Despite the advantages of HIIT, it is important to identify methods of implementing exercise trials that can successfully reach and maintain participation in larger cohorts.
Recent work by the investigative group demonstrated that individuals with SCI expressed favorable perceptions of home-exercise training that incorporated telehealth technology, which allowed a fitness specialist to remotely monitor participants' training progress in real-time and provide verbal support via videoconferencing.
This method of training holds even greater value for home-exercise programs that require monitoring to dose-specific protocols such as HIIT.
However, the long-term success of HIIT will greatly depend on the ease at which the program can be implemented, as well as participants' adherence and perceptions of using the technology, which has not been investigated in SCI.
The goal of this study is to integrate a home-based telehealth HIIT arm crank exercise training program in individuals with SCI and assess changes in cardiometabolic health and physical function.
The secondary goal is to explore the uptake and implementation of HIIT in SCI.
40 participants will be randomized to home-based HIIT exercise or a no-exercise control group for 16-weeks.
Body composition, aerobic fitness, muscular strength, and changes in cardiometabolic health will be assessed at baseline and 16-weeks post training.
In addition to changes in cardiometabolic health outcomes, the investigators will also conduct interviews with participants to determine overall perceptions of the program, program likes and dislikes, perceived satisfaction and value, usability of equipment and technology, and factors that influence adherence.
Study Type
Interventional
Enrollment (Actual)
8
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Alabama
-
Birmingham, Alabama, United States, 35294
- University of Alabama at Birmingham
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years to 61 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Description
Inclusion Criteria:
- Men and women, 19-65 years of age.
- Confirmed diagnosis of traumatic SCI at the cervical or thoracic level (C7-T12), classified as A, B, C, or D (motor and sensory complete or incomplete) on the AIS scale.
- At least 6 months post-injury.
- Able to independently operate an arm ergometer.
- Have access to a wireless internet connection.
- Medically stable, able to provide informed consent.
Exclusion Criteria:
- Cardiovascular or renal diseases.
- Pregnant women
- Orthopedic conditions that prevents arm ergomtery
- Upper extremity musculoskeletal conditions that prevents arm ergometry.
- Neurological disorder that prevents arm ergometry
- Participation in a structured exercise program currently or in the past 3 months.
Unable to perform exercise interventions
-
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: High intensity interval exercise
High intensity interval arm crank exercise
|
HIIT training will be delivered two times per week for 16 weeks (32 sessions).
Each session will be separated by at least 24-hrs.
Participants will be allowed to choose the days and times that they feel exercise will fit into their schedule.
The HIIT protocol will be determined based on peak anaerobic power measures during an arm crank Wingate Cycle test.
HIIT will consist of 20 minutes of exercise consisting of four minutes of arm crank exercise at 5% of peak anaerobic power followed by 30 seconds at 30% of the peak anaerobic power; this cycle will be repeated four times, ending with two minutes of recovery at 5% of peak anaerobic power.
|
|
Other: No-Exercise Control
No-exercise control group
|
No-exercise control group
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Aerobic Capacity Baseline
Time Frame: baseline
|
All subjects will undergo a progressive peak oxygen assessment to determine aerobic capacity at the Lakeshore Foundation Exercise Physiology Facility.
Subjects will be instructed to perform arm crank ergometer (Lode) at 10W for 2 min.
Every 2 min thereafter, power output will be increased by 10W until voluntary fatigue.
Peak aerobic power will be defined as VO2 at the point of failure to maintain 60-65 rotations per minute.
|
baseline
|
|
Aerobic Capacity Week 16
Time Frame: 16weeks post training
|
All subjects will undergo a progressive peak oxygen assessment to determine aerobic capacity at the Lakeshore Foundation Exercise Physiology Facility.
Subjects will be instructed to perform arm crank ergometer (Lode) at 10W for 2 min.
Every 2 min thereafter, power output will be increased by 10W until voluntary fatigue.
Peak aerobic power will be defined as VO2 at the point of failure to maintain 60-65 rotations per minute.
|
16weeks post training
|
|
Matsuda Index Baseline
Time Frame: baseline
|
Oral glucose tolerance test.
Following an overnight fast each subject will consume a 75g oral glucose load within 5 min.
Blood samples will be collected immediately before and 60, 90, and 120 min following glucose ingestion for measurement of serum glucose and serum insulin.
Insulin sensitivity was calculated using glucose and insulin values by the Matsuda Index, in which a higher number demonstrates an improvement in insulin sensitivity,
|
baseline
|
|
Matsuda Index Week 16
Time Frame: 16weeks post training
|
Oral glucose tolerance test.
Following an overnight fast each subject will consume a 75g oral glucose load within 5 min.
Blood samples will be collected immediately before and 60, 90, and 120 min following glucose ingestion for measurement of serum glucose and serum insulin.
Insulin sensitivity was calculated using glucose and insulin values by the Matsuda Index, in which a higher number demonstrates an improvement in insulin sensitivity,
|
16weeks post training
|
|
Cholesterol Baseline
Time Frame: baseline
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
baseline
|
|
Cholesterol Week 16
Time Frame: 16weeks post training
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
16weeks post training
|
|
Body Composition Baseline
Time Frame: baseline
|
Dual-energy X-ray absorptiometry (DXA).
Percent Body Fat
|
baseline
|
|
Body Composition Week 16
Time Frame: 16weeks post training
|
Dual-energy X-ray absorptiometry (DXA).
Percent Body Fat
|
16weeks post training
|
|
Triglycerides Baseline
Time Frame: baseline
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
baseline
|
|
Triglycerides Week 16
Time Frame: 16-weeks post
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
16-weeks post
|
|
HDL Baseline
Time Frame: Baseline
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
Baseline
|
|
HDL Week 16
Time Frame: 16-weeks post training
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
16-weeks post training
|
|
LDL Baseline
Time Frame: Baseline
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
Baseline
|
|
LDL Week 16
Time Frame: 16-weeks post training
|
Laboratory analyses.
Concentrations of blood lipids will be determined in the Core Laboratory of the CCTS, NORC, and DRC.
|
16-weeks post training
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Semi-Structured Interview
Time Frame: 16 weeks post-training
|
The semi-structured interviews will contain seven open-ended questions related to the following areas: 1) overall perceptions of the program, 2) program likes, 3) dislikes, 4) perceived satisfaction and 5) value, 6) technology and equipment usability, and 7) factors that affected adherence.
These areas will be probed in greater detail by the interviewer through additional follow-up questions.
|
16 weeks post-training
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Collaborators
Investigators
- Principal Investigator: Gordon Fisher, PhD, University of Alabama at Birmingham
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2021
Primary Completion (Actual)
July 31, 2023
Study Completion (Actual)
July 31, 2023
Study Registration Dates
First Submitted
June 16, 2021
First Submitted That Met QC Criteria
June 24, 2021
First Posted (Actual)
June 25, 2021
Study Record Updates
Last Update Posted (Actual)
July 24, 2024
Last Update Submitted That Met QC Criteria
July 2, 2024
Last Verified
July 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 000526083
- R21NR019309 (U.S. NIH Grant/Contract)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Injuries
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruitingInjury, Spinal Cord
-
Khon Kaen UniversityUnknownInjuries, Spinal Cord
-
Universidade do Vale do ParaíbaCompletedInjuries, Spinal Cord
-
Institut GuttmannNot yet recruitingSpinal Cord Injury | Spinal Cord Disease | Spinal Cord Injuries (SCI) | Traumatic Spinal Cord InjuriesSpain
-
InVivo TherapeuticsTerminated
-
Ekso BionicsBurke Medical Research InstituteCompletedInjuries, Spinal CordUnited States
-
ReWalk Robotics, Inc.Unknown
-
Chang Gung Memorial HospitalNot yet recruitingSpine Injury | Complete Spinal Cord Injury | Incomplete Spinal Cord Injury | Cord Injury, Spinal | Cord Infarction Spinal
-
Kessler FoundationNot yet recruitingSpinal Cord Injury | Spinal Cord Disease | Spinal Cord Injuries (SCI)United States
Clinical Trials on high intensity interval exercise
-
University of GuelphCompletedPost-Exercise Hypotension | Ambulatory Blood Pressure Monitoring | High-intensity Interval ExerciseCanada
-
Laboratoire des Adaptations Métaboliques à l'Exercice...CREPS Auvergne Rhône-Alpes / VichyCompletedOverweight | PostmenopausalFrance
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
Norwegian University of Science and TechnologySt. Olavs Hospital; Liverpool John Moores University; Australian Catholic UniversityCompletedPolycystic Ovary SyndromeAustralia, Norway
-
New York State Psychiatric InstituteColumbia UniversityCompleted
-
Steno Diabetes Center CopenhagenRecruiting
-
Kaohsiung Medical University Chung-Ho Memorial...Ministry of Science and Technology, TaiwanRecruiting
-
Nationwide Children's HospitalCompleted
-
Ahlia UniversityCairo UniversityCompletedObesity | Diabetes | Exercise | Nonalcoholic Fatty Liver DiseaseEgypt
-
University of AlbertaAlberta Diabetes InstituteCompletedExercise Intensity, Glycemic Control and Abdominal Fat in People With Type 2 Diabetes: A Pilot StudyType 2 Diabetes MellitusCanada